Global Genetic Analysis Market to Reach US$16.5 Billion by 2030
The global market for Genetic Analysis estimated at US$11.6 Billion in the year 2024, is expected to reach US$16.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 9.6% CAGR
The Genetic Analysis market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.
Global Genetic Analysis Market - Key Trends & Drivers Summarized
Why Is Genetic Analysis Revolutionizing Healthcare and Scientific Research?
Genetic analysis has transformed healthcare, agriculture, and biomedical research by providing critical insights into DNA sequences, genetic variations, and disease predisposition. Advances in next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies have enabled researchers to decode genetic information with unprecedented accuracy and speed. These techniques allow for the identification of hereditary diseases, early cancer detection, and personalized medicine approaches, revolutionizing patient care and disease management.
Beyond healthcare, genetic analysis plays a crucial role in forensic science, evolutionary biology, and agriculture. In forensic investigations, DNA profiling has enhanced crime-solving capabilities, while in agriculture, genetic analysis has facilitated the breeding of high-yield, disease-resistant crops. The increasing accessibility of direct-to-consumer (DTC) genetic testing has also driven market growth, allowing individuals to gain insights into their ancestry, health risks, and inherited traits. As the applications of genetic analysis continue to expand, the demand for high-throughput sequencing and bioinformatics solutions is rising across multiple industries.
Which Industries Are Driving the Demand for Genetic Analysis?
The healthcare sector is the largest consumer of genetic analysis technologies, leveraging genomic insights for disease risk assessment, precision medicine, and reproductive health screening. Oncology has been a primary focus area, with genetic tests guiding targeted cancer therapies based on a patient’s unique genetic profile. Additionally, genetic screening for rare diseases, prenatal testing, and pharmacogenomics has significantly improved early diagnosis and treatment planning.
In agriculture, genetic analysis is playing a pivotal role in crop improvement and livestock breeding. By identifying genes associated with yield, disease resistance, and environmental adaptability, researchers are developing genetically optimized crops to address global food security challenges. The biotechnology and pharmaceutical industries also rely on genetic analysis for drug discovery, gene therapy research, and microbiome analysis. With continuous advancements in sequencing technologies and AI-driven bioinformatics, genetic analysis is becoming an integral part of research and commercial applications.
What Are the Latest Technological Innovations in Genetic Analysis?
Technological innovations in genetic analysis have significantly enhanced sequencing accuracy, data processing speed, and cost-effectiveness. The development of single-cell sequencing has enabled scientists to analyze genetic variations at the cellular level, improving cancer diagnostics and neuroscience research. Additionally, the integration of AI and machine learning in bioinformatics has accelerated genome annotation, variant interpretation, and disease risk prediction.
Long-read sequencing technologies, such as PacBio and Oxford Nanopore, have further expanded the capabilities of genetic analysis by providing more comprehensive insights into complex genomic structures. Advances in CRISPR-based gene editing and synthetic biology are also complementing genetic analysis, allowing researchers to modify DNA sequences with high precision. As genetic research continues to evolve, these innovations are expected to drive the next generation of diagnostic, therapeutic, and agricultural breakthroughs.
What Factors Are Fueling the Growth of the Genetic Analysis Market?
The growth in the genetic analysis market is driven by several factors, including increasing demand for precision medicine, rising adoption of NGS technologies, and expanding applications in agriculture and biotechnology. The declining cost of DNA sequencing has made genetic analysis more accessible, enabling large-scale population genomics projects and personalized healthcare initiatives. Additionally, government funding and private investments in genomic research have accelerated technological advancements and commercial adoption.
The growing prevalence of genetic disorders and cancer has further increased the need for genetic screening and early diagnostics. The direct-to-consumer genetic testing market is also expanding, as consumers seek insights into their health, ancestry, and lifestyle predispositions. Moreover, the integration of cloud computing and AI in genetic data analysis has improved efficiency and scalability, driving market expansion. As genetic analysis becomes an essential tool across multiple industries, its adoption is expected to continue growing, shaping the future of genomics-driven innovation and personalized medicine.
SCOPE OF STUDY:
The report analyzes the Genetic Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Reagents & Kits, Instruments, Software); Test (Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests); Technology (Next-Generation Sequencing Technology, Real-Time PCR System Technology, Other Technologies); Application (Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application, Other Applications); End-Use (Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
Autumn DNA
Blueprint Genetics
Caris Life Sciences
Color Health, Inc.
Coriell Life Sciences
deCODE genetics
Exact Sciences Corporation
Foundation Medicine
Fulgent Genetics
Gene by Gene
Genomic Life
Guardant Health
Illumina, Inc.
Invitae Corporation
Myriad Genetics
NeoGenomics Laboratories
Newtopia Inc.
Qiagen N.V.
Sophia Genetics
Thermo Fisher Scientific
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Genetic Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Explosion of Genomic Data and Falling Sequencing Costs Drive Rapid Expansion of Genetic Analysis Applications
Increased Adoption of Genetic Testing for Personalized Medicine Fuels Growth in Diagnostic and Predictive Genomics
Expansion of Population-Scale Genomics Programs Spurs Demand for High-Throughput Genetic Analysis Platforms
Wider Use of NGS, qPCR, and Microarrays Across Research and Clinical Applications Broadens Technology Adoption
Rising Investment in Precision Oncology and Companion Diagnostics Accelerates Genetic Biomarker Discovery
OEM Integration of AI and Bioinformatics in Genetic Analysis Enhances Interpretation Accuracy and Clinical Relevance
Demand for Preimplantation and Prenatal Genetic Testing Grows in Line with Advancements in Reproductive Health
Growth in Consumer Genomics and Direct-to-Consumer Testing Platforms Spurs Market Awareness and Uptake
Expansion of Pharmacogenomics in Drug Development Supports Broader Adoption in Clinical Trials
Integration of Epigenetic and Transcriptomic Analysis Expands Multi-Omics Research Scope
OEM Partnerships with Biopharma Companies Strengthen Validation of Genetic Biomarkers for Drug Targeting
Rising Role of Genetic Analysis in Rare Disease Diagnosis Enhances Access to Precision Healthcare Solutions
Healthcare Payer Support and Reimbursement for Genetic Tests Drives Broader Adoption in Clinical Settings
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Genetic Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Next-Generation Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Real-Time PCR System Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Genetic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Rare Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Research & Development Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 48: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 53: World Recent Past, Current & Future Analysis for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 54: World Historic Review for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: World 15-Year Perspective for Predictive Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 56: World Recent Past, Current & Future Analysis for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 57: World Historic Review for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: World 15-Year Perspective for Carrier Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 59: World Recent Past, Current & Future Analysis for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 60: World Historic Review for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: World 15-Year Perspective for Prenatal & Newborn Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 62: World Recent Past, Current & Future Analysis for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 63: World Historic Review for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: World 15-Year Perspective for Disease Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 65: World Recent Past, Current & Future Analysis for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 66: World Historic Review for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: World 15-Year Perspective for Pharmacogenomic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 68: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 69: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: World 15-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 71: USA Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: USA Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: USA 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 74: USA Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: USA Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: USA 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 77: USA Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: USA Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: USA 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 80: USA Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: USA Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: USA 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 83: USA Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: USA Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: USA 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
CANADA
TABLE 86: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Canada Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Canada 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 89: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Canada Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Canada 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 92: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Canada Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Canada 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 95: Canada Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Canada Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Canada 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 98: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Canada Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Canada 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
JAPAN
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 101: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Japan Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Japan 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 104: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Japan Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Japan 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 107: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Japan Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Japan 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 110: Japan Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Japan Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Japan 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 113: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Japan Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Japan 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
CHINA
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 116: China Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: China Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: China 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 119: China Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: China Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: China 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 122: China Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: China Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: China 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 125: China Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: China Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: China 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 128: China Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: China Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: China 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
EUROPE
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 131: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 132: Europe Historic Review for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Europe 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 134: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 137: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 140: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 143: Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 146: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
FRANCE
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 149: France Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: France Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: France 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 152: France Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: France Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: France 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 155: France Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: France Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: France 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 158: France Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: France Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: France 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 161: France Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: France Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: France 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
GERMANY
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 164: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Germany Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Germany 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 167: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Germany Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Germany 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 170: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Germany Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Germany 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 173: Germany Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Germany Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Germany 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 176: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Germany Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Germany 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
ITALY
TABLE 179: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Italy Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: Italy 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 182: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Italy Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: Italy 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 185: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: Italy Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: Italy 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 188: Italy Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Italy Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: Italy 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 191: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Italy Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: Italy 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
UNITED KINGDOM
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 194: UK Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: UK Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: UK 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 197: UK Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: UK Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: UK 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 200: UK Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: UK Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: UK 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 203: UK Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: UK Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: UK 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 206: UK Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: UK Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: UK 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
SPAIN
TABLE 209: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Spain Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Spain 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 212: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Spain Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Spain 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 215: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Spain Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Spain 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 218: Spain Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Spain Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Spain 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 221: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Spain Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Spain 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
RUSSIA
TABLE 224: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Russia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Russia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 227: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Russia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Russia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 230: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Russia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Russia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 233: Russia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Russia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Russia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 236: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Russia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Russia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 245: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 248: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 251: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Rest of Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Rest of Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 255: Asia-Pacific Historic Review for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Asia-Pacific 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 263: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 269: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
AUSTRALIA
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 272: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Australia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Australia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 275: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Australia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Australia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 278: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Australia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Australia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 281: Australia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Australia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Australia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 284: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Australia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: Australia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
INDIA
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 287: India Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: India Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: India 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 290: India Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: India Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: India 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 293: India Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: India Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: India 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 296: India Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: India Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: India 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 299: India Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: India Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: India 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 302: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: South Korea Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: South Korea 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 305: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: South Korea Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: South Korea 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 308: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: South Korea Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: South Korea 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 311: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: South Korea Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: South Korea 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 314: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: South Korea Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: South Korea 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 318: Rest of Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 321: Rest of Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 322: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 323: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 324: Rest of Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 325: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 326: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 327: Rest of Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 328: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 329: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 330: Rest of Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 331: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
LATIN AMERICA
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 332: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 333: Latin America Historic Review for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 334: Latin America 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 335: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 336: Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 337: Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 338: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 339: Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 340: Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 341: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 342: Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 343: Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 344: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 345: Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 346: Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 347: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 348: Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 349: Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 350: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 351: Argentina Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 352: Argentina 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 353: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 354: Argentina Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 355: Argentina 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 356: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 357: Argentina Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 358: Argentina 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 359: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 360: Argentina Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 361: Argentina 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 362: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 363: Argentina Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 364: Argentina 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
BRAZIL
TABLE 365: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 366: Brazil Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 367: Brazil 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 368: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 369: Brazil Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 370: Brazil 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 371: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 372: Brazil Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 373: Brazil 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 374: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 375: Brazil Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 376: Brazil 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 377: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 378: Brazil Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 379: Brazil 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
MEXICO
TABLE 380: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 381: Mexico Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 382: Mexico 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 383: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 384: Mexico Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 385: Mexico 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 386: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 387: Mexico Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 388: Mexico 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 389: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 390: Mexico Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 391: Mexico 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 392: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 393: Mexico Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 394: Mexico 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 396: Rest of Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 397: Rest of Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 399: Rest of Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 400: Rest of Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 401: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 402: Rest of Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 403: Rest of Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 404: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 405: Rest of Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 406: Rest of Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 407: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 408: Rest of Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 409: Rest of Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
MIDDLE EAST
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 410: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 411: Middle East Historic Review for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 412: Middle East 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 413: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 414: Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 415: Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 416: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 417: Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 418: Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 419: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 420: Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 421: Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 422: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 423: Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 424: Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 425: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 426: Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 427: Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
IRAN
TABLE 428: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 429: Iran Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 430: Iran 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 431: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 432: Iran Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 433: Iran 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 434: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 435: Iran Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 436: Iran 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 437: Iran Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 438: Iran Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 439: Iran 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 440: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 441: Iran Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 442: Iran 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
ISRAEL
TABLE 443: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 444: Israel Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 445: Israel 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 446: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 447: Israel Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 448: Israel 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 449: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 450: Israel Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 451: Israel 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 452: Israel Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 453: Israel Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 454: Israel 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 455: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 456: Israel Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 457: Israel 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 459: Saudi Arabia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 460: Saudi Arabia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 462: Saudi Arabia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 463: Saudi Arabia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 464: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 465: Saudi Arabia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 466: Saudi Arabia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 467: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 468: Saudi Arabia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 469: Saudi Arabia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 470: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 471: Saudi Arabia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 472: Saudi Arabia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 473: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 474: UAE Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 475: UAE 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 476: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 477: UAE Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 478: UAE 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 479: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 480: UAE Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 481: UAE 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 482: UAE Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 483: UAE Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 484: UAE 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 485: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 486: UAE Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 487: UAE 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 489: Rest of Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 490: Rest of Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 492: Rest of Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 493: Rest of Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 494: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 495: Rest of Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 496: Rest of Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 497: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 498: Rest of Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 499: Rest of Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 500: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 501: Rest of Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 502: Rest of Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
AFRICA
Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 503: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 504: Africa Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 505: Africa 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
TABLE 506: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 507: Africa Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 508: Africa 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
TABLE 509: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 510: Africa Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 511: Africa 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
TABLE 512: Africa Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 513: Africa Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 514: Africa 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 515: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 516: Africa Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 517: Africa 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030